Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: Results from a randomized clinical trial with 1-year follow-up

Archives of Internal Medicine

Volumn 160, Issue 8, 2000, Pages 1101-1108

  Thompson, Bruce ^a  

^a Clinical Trials & Surveys Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROMYOGRAM; FEEDBACK SYSTEM; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SUSTAINED RELEASE PREPARATION; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME; VERTIGO;

EID: 0034709061     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.8.1101     Document Type: Article

References (49)

1. LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992;10:485-488.
2. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC. USA vs. Tarentaise, Savoie, France. J Rheumatol. 1993;20:70-76.
3. Creager MA, Halperin JL, Coffman JD. Vasospastic diseases. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular Medicine. Boston, Mass: Little Brown & Co Inc; 1992;975-1010.
4. Sarkozi J, Bookman AA, Mahon W, Ramsay C, Detsky AS, Keystone EC. Nifedipine in the treatment of idiopathic Raynaud's syndrome. J Rheumatol. 1986; 13:331-336.
5. Gjorup T, Kelbaek H, Hartling OJ, Nielsen SL. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon. Am Heart J. 1986;111:742-745.
6. Corbin DO, Wood DA, Macintyre CC, Housley E. A randomized double-blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. Eur Heart J. 1986;7:165-170.
7. Rademaker M, Cooke ED, Almond NE, et al. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. BMJ. 1989; 298:561-564.
8. Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H. Nifedipine in Raynaud's phenomenon: relationship between immediate, short-term and long-term effects. J Rheumatol. 1987;14:284-290.
9. Ettinger WH, Wise RA, Schaffhauser D, Wigley FM. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon. Am J Med. 1984;77:451-456.
10. Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med. 1983;308: 880-883.
11. Gjorup T, Hartling OJ, Kelbaek H, Nielsen SL. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon. Eur J Clin Pharmacol. 1986;31:387-389.
12. Freedman RR. Physiological mechanisms of temperature biofeedback. Biofeedback Self Regul. 1991;16:95-115.
13. Jobe JB, Sampson JB, Roberts DE, Beetham WP Jr. Induced vasodilationas treatment for Raynaud's disease. Ann Intern Med. 1982;97:706-709.
14. Appiah R. Hiller S, Caspary L, Alexander K, Creutzig A. Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture. J Intern Med. 1997; 241:119-124.
15. Surwit RS. Biofeedback: a possible treatment for Raynaud's disease. Semin Psychiatry. 1973;5:483-490.
16. Jacobson AM, Hackett TP, Surman OS, Silverberg EL. Raynaud phenomenon: treatment with hypnotic and operant technique. JAMA. 1973;225:739-740.
17. Blanchard EB, Haynes M. Biofeedback treatment of a case of Raynaud's disease. J Behav Ther Exp Psychiatry. 1975;6:230-234.
18. Shapiro D, Schwartz GE. Biofeedback and visceral learning: clinical applications. Semin Psychiatry. 1972;4:171-184.
19. Jacobson AM, Manschreck TC, Silverberg E. Behavioral treatment for Raynaud's disease: a comparative study with long-term follow-up. Am J Psychiatry. 1979; 136:844-846.
20. Surwit RS, Pilon RN, Fenton CH. Behavioral treatment of Raynaud's disease. J Behav Med. 1978;1:323-335.
21. Keefe FJ, Surwit RS, Pilon RN. A 1-year follow-up of Raynaud's patients treated with behavioral therapy techniques. J Behav Med. 1979;2:385-391.
22. Keefe F, Gardner E. Learned control of skin temperature: effects of short-and long-term biofeedback training. Behav Ther. 1979;10:202-210
23. Freedman RR, Ianni P. Self-control of digital temperature: physiological factors and transfer effects. Psychophysiology. 1983;20:682-689.
24. Grabert JC, Bregman NJ, McAllister HA. Skin temperature regulation: the effects of suggestion and feedback. Int J Neurosci. 1980;10:217-221.
25. Keefe FJ. Biofeedback vs. instructional control of skin temperature. J Behav Med. 1978;1:383-390.
26. Stoffer GR, Jensen JA, Nesset BL. Effects of contingent versus yoked temperature feedback on voluntary temperature control and cold stress tolerance. Biofeedback Self Regul. 1979;4:51-61.
27. Freedman RR, Ianni P, Wenig P. Behavioral treatment of Raynaud's disease. J Consult Clin Psychol. 1983;51:539-549.
28. Stambrook M, Hamel ER, Carter SA. Training to vasodilate in a cooling environment: a valid treatment for Raynaud's phenomenon? Biofeedback Self Regul. 1988; 13:9-23.
29. King NJ, Montgomery RB. Biofeedback-induced control of human peripheral temperature: a critical review of the literature. Psych Bull. 1980;88:738-752.
30. Rose GD, Carlson JG. The behavioral treatment of Raynaud's disease: a review. Biofeedback Self Regul. 1987;12:257-272.
31. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol. 1997; 24:879-889.
32. Maricq HR. Capillaroscopy in Raynaud's syndrome. Vasc Med Rev. 1992;3:3-20.
33. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Mass: Nimrod Press; 1993.
34. Cohen S, Hoberman HM. Positive events and social supports as buffers of life change stress. J Appl Soc Psychol. 1983;13:99-125.
35. Friou GJ. Clinical application of lupus serum-nucleoprotein reaction using fluorescent antibody technique [abstract]. J Clin Invest. 1957;36:890.
36. Thompson B, Geller N, Hunsberger S, et al. Designing clinical trials with behavioral and pharmacologic interventions: the Raynaud's Treatment Study. Control Clin Trials. 1999;20:52-63.
37. Kotz S, Johnson NL, Read CB, eds. Encyclopedia of Statistical Sciences. New York, NY: John Wiley & Sons Inc; 1983:397-400.
38. Rubin D. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91:473-489.
39. SAS Institute Inc. SAS Language: Reference, Version 6. Cary, NC: SAS Institute Inc; 1990.
40. Wigley FM. Raynaud's phenomenon. In: Fortuin NJ, ed. Current Therapy in Cardiovascular Disease. Philadelphia. Pa: BC Decker Inc; 1987:319-322.
41. Adee AC. Managing Raynaud's phenomenon: a practical approach. Am Fam Physician. 1993;47:823-829.
42. Ferri C, Cecchetti R, Cini G, et al. Slow-releasing nicardipine in the treatment of Raynaud's phenomena without underlying diseases. Clin Rheumatol. 1992;11: 76-80.
43. Rhedda A, McCans J, Willan AR, Ford PM. A double blind placebo controlled cross-over randomized trial of diltiazem in Raynaud's phenomenon. J Pheumatol. 1985; 12:724-727.
44. Leppert J, Jonasson T, Nilsson H, Ringqvist I. The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study. Cardiovasc Drugs Ther. 1989;3:397-401.
45. Freedman RR, Keegan D, Migaly P, Galloway M, Mayes M. Plasma catecholamines during behavioral treatments for Raynaud's disease. Psychosom Med. 1991;53:433-439.
46. Freedman RR, Sabharwal S, Ianni P, Desai N, Wenig P, Mayes M. Non-neural beta-adrenergic vasodilating mechanism in temperature biofeedback. Psychosom Med. 1988;50:394-401.
47. Freedman RR. Quantitative measurements of finger blood flow during behavioral treatments for Raynaud's disease. Psychophysiology. 1989;26:437-441.
48. Otis JD, Rasey HW, Vrochopoulos S, Wincze JP, Andrasik F. Temperature acquisition as a function of the computer-based biofeedback system utilized: an exploratory analysis. Biofeedback Self Regul. 1995;20:185-190.
49. Freedman RR, Ianni P, Wenig P. Behavioral treatment of Raynaud's disease: long-term follow-up. J Consult Clin Psychol. 1985;53:136.